enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q4 2024
Institutional positions in enGene Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +5 vs. Q3 2024
- Shares held
- 41.3M
- +7.17M (+21.0%) vs. Q3 2024
- Total value
- $274.7M
- +$48.0M (+21.2%) vs. Q3 2024
- New holders
- 12
- 10 more added
- Sold out
- 7
- 7 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FCPM III Services B.V. | 9,632,561 | $64.1M | 10.81% | +954,610+11.0% | Added |
| VR Adviser, LLC | 5,046,414 | $33.6M | 2.30% | +1,480,573+41.5% | Added |
| Kynam Capital Management, LP | 4,994,090 | $33.2M | 2.19% | +3,257,863+187.6% | Added |
| Deep Track Capital, LP | 4,557,575 | $30.3M | 1.14% | +1,949,942+74.8% | Added |
| Blue Owl Capital Holdings LP | 3,159,975 | $21.0M | 4.97% | +101,006+3.3% | Added |
| Cormorant Asset Management, LP | 2,323,595 | $15.5M | 0.85% | +1,323,595+132.4% | Added |
| BVF Inc | 2,106,037 | $14.0M | 0.47% | −145,000−6.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,529,768 | $10.2M | 0.02% | −800,000−34.3% | Reduced |
| Point72 Asset Management, L.P. | 1,224,797 | $8.14M | 0.02% | +561,797+84.7% | Added |
| Franklin Resources Inc | 1,189,952 | $7.91M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 920,339 | $6.12M | 0.13% | +920,339 | New |
| Goldman Sachs Group Inc | 899,086 | $5.98M | 0.00% | +899,086 | New |
| Sr One Capital Management, LP | 747,750 | $4.97M | 1.21% | 00.0% | Unchanged |
| Marshall Wace, LLP | 593,742 | $3.95M | 0.00% | −87,803−12.9% | Reduced |
| Sphera Funds Management Ltd. | 560,000 | $3.72M | 0.69% | +560,000 | New |
| Omega Fund Management, LLC | 526,357 | $3.50M | 2.27% | −550,000−51.1% | Reduced |
| Morgan Stanley | 438,772 | $2.92M | 0.00% | +430,579+5,255.4% | Added |
| Vestal Point Capital, LP | 370,000 | $2.46M | 0.15% | +370,000 | New |
| Schonfeld Strategic Advisors LLC | 132,260 | $879.5K | 0.01% | −173,774−56.8% | Reduced |
| Sectoral Asset Management Inc | 78,919 | $524.8K | 0.35% | −15,300−16.2% | Reduced |
| MAI Capital Management | 70,311 | $467.6K | 0.00% | +70,311 | New |
| Two Sigma Investments, LP | 35,866 | $238.5K | 0.00% | −3,755−9.5% | Reduced |
| Northern Trust Corp | 34,416 | $228.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 29,018 | $193.0K | 0.00% | +1,502+5.5% | Added |
| Corton Capital Inc. | 23,601 | $156.9K | 0.09% | +23,601 | New |
| Cubist Systematic Strategies, LLC | 15,342 | $102.0K | 0.00% | +2,080+15.7% | Added |
| Pale Fire Capital SE | 14,710 | $97.8K | 0.02% | +14,710 | New |
| Toronto Dominion Bank | 14,537 | $96.7K | 0.00% | +14,537 | New |
| Jane Street Group, LLC | 14,038 | $93.4K | 0.00% | +14,038 | New |
| Vontobel Holding Ltd. | 10,417 | $69.3K | 0.00% | +10,417 | New |
| Royal Bank of Canada | 7,915 | $53.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,200 | $7.98K | 0.00% | +1,200 | New |
| Wells Fargo & Company | 1,138 | $7.57K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 30 | $200 | 0.00% | +30 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −727,900−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −678,705−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −5,574−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −1,970−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |